centchroman has been researched along with tamoxifen in 20 studies
| Studies (centchroman) | Trials (centchroman) | Recent Studies (post-2010) (centchroman) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
|---|---|---|---|---|---|
| 157 | 12 | 47 | 20,630 | 2,227 | 6,256 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 10 (50.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kon, OL; Ng, SC; Sim, KY; Teo, CC | 1 |
| Kamboj, VP; Malaviya, B; Paliwal, A | 1 |
| Devi, PK | 1 |
| Chauhan, SC; Dwivedi, A; Kamboj, VP; Singh, MM; Trivedi, RN | 1 |
| Kamboj, VP; Singh, MM; Sreenivasulu, S | 1 |
| Dwivedy, I; Katzenellenbogen, JA; O'Neil, JP; Ray, S; Tandon, A; Wilson, SR | 1 |
| Chauhan, SC; Kamboj, VP; Maitra, SC; Singh, MM | 1 |
| Blair, HC; Jordan, SE; McDonald, JM; McKenna, MA; Radding, W; Williams, JP | 1 |
| Allag, IS; Rangari, K | 1 |
| Giri, AK; Gupta, S; Mukhopadhyay, A; Ray, S | 2 |
| Giri, AK; Mukhopadhyay, A; Ray, S | 1 |
| Arshad, M; Ghosh, R; Sawlani, V; Sengupta, S; Sharma, S; Singh, MM | 1 |
| Balapure, AK; Nigam, M; Ranjan, V; Sharma, R; Srivastava, S | 1 |
| Balapure, AK; Gupta, DK; Nigam, D; Nigam, M; Ranjan, V; Sharma, R; Singh, N; Sundaram, S; Zaidi, D | 1 |
| Dalela, D; Gupta, G; Jain, A; Jain, RK; Kumar, R; Maikhuri, JP; Sarswat, A; Sharma, VL; Verma, V | 1 |
| Ali, MM; Jain, GK; Kohli, K; Singh, SP | 1 |
| Hou, J; Li, P; Mi, M; Xiong, X; Xu, X; Zeng, J | 1 |
| Bansal, A; Choudhary, D; Garg, PK; Jain, BK; Mohanty, D | 1 |
| Gayen, JR; Hussain, KM; Mishra, DP; Rama Raju, KS; Singh, SK; Singh, SP; Taneja, I; Tripathi, A; Wahajuddin, M | 1 |
1 review(s) available for centchroman and tamoxifen
| Article | Year |
|---|---|
Antiestrogens.
Topics: Animals; Centchroman; Chemical Phenomena; Chemistry; Clomiphene; Estrogen Antagonists; Humans; Nafoxidine; Tamoxifen | 1981 |
1 trial(s) available for centchroman and tamoxifen
| Article | Year |
|---|---|
Centchroman vs tamoxifen for regression of mastalgia: a randomized controlled trial.
Topics: Adult; Centchroman; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Mastodynia; Pain Measurement; Tamoxifen; Time Factors; Treatment Outcome; Young Adult | 2015 |
18 other study(ies) available for centchroman and tamoxifen
| Article | Year |
|---|---|
Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.
Topics: Benzofurans; Binding Sites; Binding, Competitive; Cell Division; Cell Line; Cholesterol; Estrogen Antagonists; Humans; Ligands; Receptors, Estrogen; Thymidine | 1992 |
Effect of centchroman and tamoxifen on protein patterns of fallopian tubes of rhesus monkeys, Macaca mulatta.
Topics: Animals; Centchroman; Estradiol; Fallopian Tubes; Female; Macaca mulatta; Protein Biosynthesis; Proteins; Tamoxifen | 1992 |
Time-related effects of a triphenylethylene antiestrogen on estrogen-induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in rats.
Topics: Administration, Oral; Animals; Centchroman; Decidua; Dose-Response Relationship, Drug; Endometrium; Epithelium; Estradiol; Estrogen Antagonists; Female; Microscopy, Electron, Scanning; Nafoxidine; Organ Size; Ovariectomy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen; Time Factors; Uterus | 1995 |
Duration of anti-implantation action of the triphenylethylene anti-oestrogen centchroman in adult female rats.
Topics: Administration, Oral; Animals; Centchroman; Embryo Implantation; Embryo Implantation, Delayed; Female; Rats; Rats, Sprague-Dawley; Tamoxifen; Time Factors | 1994 |
An X-ray crystallographic study of the nonsteroidal contraceptive agent centchroman.
Topics: Centchroman; Crystallization; Crystallography, X-Ray; Estradiol; Iodides; Methylation; Molecular Conformation; Molecular Structure; Nafoxidine; Receptors, Estrogen; Stereoisomerism; Tamoxifen | 1994 |
Inhibition of progesterone-induced development of giant mitochondria in uterine glandular epithelial cells by an antiestrogen in rat.
Topics: Animals; Centchroman; Cohort Studies; Epithelial Cells; Epithelium; Estradiol; Estrogen Antagonists; Female; Microscopy, Electron; Mitochondria; Ovariectomy; Progesterone; Random Allocation; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterus | 1996 |
Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding.
Topics: Animals; Anticarcinogenic Agents; Benzopyrans; Bone Resorption; Calmodulin; Centchroman; Cyclic Nucleotide Phosphodiesterases, Type 1; Dose-Response Relationship, Drug; Female; Osteoclasts; Phosphoric Diester Hydrolases; Piperidines; Proton-Translocating ATPases; Tamoxifen; Trifluoperazine | 1997 |
In-vitro effect of estrogen-antagonist on motility and penetration ability of human spermatozoa.
Topics: Adult; Centchroman; Estradiol; Estrogen Antagonists; Female; Humans; In Vitro Techniques; Male; Sperm Motility; Sperm-Ovum Interactions; Tamoxifen | 1997 |
Comparative antimutagenic effects of D- and L-centchroman and their comparison with tamoxifen in Salmonella assay.
Topics: Animals; Antimutagenic Agents; Cell Extracts; Centchroman; Dose-Response Relationship, Drug; Liver; Male; Mutagenicity Tests; Mutagens; Rats; Salmonella; Species Specificity; Stereoisomerism; Tamoxifen | 1999 |
Anticlastogenic effects of centchroman and its enantiomers in Swiss albino mice. I. Acute study and their comparison with tamoxifen.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antimutagenic Agents; Antineoplastic Agents; Centchroman; Chromosome Aberrations; Cyclophosphamide; Estrogen Antagonists; Female; Mice; Mice, Inbred Strains; Mutagens; Sister Chromatid Exchange; Stereoisomerism; Tamoxifen | 1999 |
Anticlastogenic effects of d- and l-centchroman in Swiss albino mice. 2. Subacute study in vivo and comparison with tamoxifen.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimutagenic Agents; Antineoplastic Agents; Bone Marrow Cells; Centchroman; Chromosome Aberrations; Cyclophosphamide; Female; Mice; Stereoisomerism; Tamoxifen | 2001 |
In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
Topics: Animals; Autopsy; Benzopyrans; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Calcium; Centchroman; Chick Embryo; Densitometry; Disease Models, Animal; Epithelial Cells; Ethinyl Estradiol; Female; Femur; Osteocalcin; Osteoporosis; Ovary; Parathyroid Hormone; Piperidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Tibia | 2004 |
Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cell Nucleus; Cell Shape; Cell Survival; Centchroman; Clinical Trials as Topic; DNA Fragmentation; Estrogen Antagonists; Female; G1 Phase; Humans; Membrane Potentials; Mitochondria; Resting Phase, Cell Cycle; Tamoxifen | 2008 |
Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Centchroman; Cycloheximide; Dactinomycin; Down-Regulation; Estrogen Antagonists; Female; Humans; Immunoprecipitation; Oxidative Stress; Tamoxifen; Up-Regulation | 2010 |
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
Topics: 5-alpha Reductase Inhibitors; Animals; Apoptosis; Aromatase; Benzopyrans; Cell Proliferation; Cell Survival; Cells, Cultured; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Finasteride; Gene Expression Regulation; Humans; Male; Piperidines; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Androgen; RNA, Messenger; Selective Estrogen Receptor Modulators; Signal Transduction; Stromal Cells; Tamoxifen; Testosterone; Tissue Culture Techniques | 2012 |
Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
Topics: Animals; Area Under Curve; Centchroman; Chromatography, Liquid; Drug Interactions; Female; Genistein; Rats; Rats, Sprague-Dawley; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Tamoxifen; Tandem Mass Spectrometry | 2011 |
[Effect of xy2004, a centchroman derivative, on proliferation of MCF-7 cells in vitro and the mechanism].
Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Proliferation; Centchroman; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; MCF-7 Cells; Proto-Oncogene Proteins c-bcl-2; Tamoxifen | 2014 |
Simultaneous determination of centchroman and tamoxifen along with their metabolites in rat plasma using LC-MS/MS.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Centchroman; Chromatography, Liquid; Female; Mammary Neoplasms, Experimental; Metabolomics; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Tamoxifen; Tandem Mass Spectrometry; Tissue Distribution | 2015 |